Janney Montgomery Scott
NVNO

Janney Montgomery Scott’s enVVeno Medical NVNO Stock Holding History

Janney Montgomery Scott’s Portfolio NVNO Stock Details NVNO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-975
Closed -$186K – 2748
2024
Q1 		$186K Buy
+975
New +$175K ﹤0.01% 2596

Other funds holding NVNO

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WIM
Westside Investment Management Santa Monica, California $653M AUM 28.36% 1-Year Est. Return

Janney Montgomery Scott's NVNO Position: Q2 2024 in Review

Janney Montgomery Scott sold out of enVVeno Medical (NVNO) in Q2 2024, closing a stake of 975 shares — an estimated $186K sold.

Janney Montgomery Scott first reported a position in NVNO in Q1 2024 and held it in 1 quarter. The position peaked at $186K in Q1 2024. 26 funds tracked by Wall St. Rank hold NVNO as of Q2 2024.

  • Janney Montgomery Scott reported no remaining enVVeno Medical position as of Q2 2024 after selling out during the quarter.
  • Janney Montgomery Scott sold 975 enVVeno Medical shares in Q2 2024, an estimated $186K.
  • Janney Montgomery Scott first reported a position in enVVeno Medical in Q1 2024 and held it in 1 quarter.
  • Janney Montgomery Scott's enVVeno Medical position peaked at $186K in Q1 2024.
  • 26 funds tracked by Wall St. Rank held enVVeno Medical as of Q2 2024.

Based on Janney Montgomery Scott's 13F filing for Q2 2024, filed 25 Jul 2024.